IMV

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IMV and buy or sell other stocks, options, and ETFs commission-free!

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. 

CEO
Andrew Hall
CEOAndrew Hall
Employees
Employees
Headquarters
Dartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded
2007
Founded2007
Employees
Employees

IMV Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
22.10
Average volume22.10
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.8225
52 Week high$0.8225
52 Week low
52 Week low
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.